In Europe, ultraviolet (UV) B phototherapy is being increasingly used for the treatment of skin disease. While this is in part due to an increased awareness of the cancer risks of photochemotherapy (PUVA) there is also evidence that a ‘new’ UVB phototherapy source (TL-01) is more effective than conventional broadband UVB sources, and is possibly as effective as PUVA. A working party of the Brit...

Since its introduction in 1988, the Philips TL01 fluorescent tube has been used successfully and safely in phototherapy for many skin diseases (3-6). A major advantage was that burning of patients could be effectively controlled compared to existing photochemo-therapy modalities and broadand small-spectrum UVB treatments.This led to 311 nm irradiation becoming the treatment of choice for condit...

INTRODUCTION Polymorphic light eruption (PLE) is a common idiopathic photodermatosis that typically presents with pruritic papular or papulovesicular lesions on sun-exposed skin between spring and autumn. In many subjects PLE is mild, and can usually be prevented by the use of broad-spectrum topical sunscreens and a gradual increase in sunlight exposure. However, in some individuals, sunlight e...

Vitiligo is a polygenic acquired skin disorder resulting from the destruction of melanocytes in epidermal cells. Conventional therapeutic options include covering agents, topical corticosteroids, immunomodulators, phototherapy with psolaren ultraviolet A (PUVA) and narrowband B (NBUVB). However, successful repigmentation these modalities expected only half patients. This study aimed to compare ...

Ashy dermatosis or erythema dyschromicum perstans (EDP) is a typically asymptomatic disease of unknown origin that causes symmetrical gray spots on the trunk and extremities (1). It was first described by Ramirez in 1957 (2). Patients show oval, irregular, or polycyclic gray macules with erythematous, inflammatory borders (3). There is no single established therapy for EDP. The aim of our study...